JERUSALEM, Israel — Teva Pharmaceutical Industries Ltd. has launched norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets 1 mg/20 mcg, a birth control pill, in the United States. Teva said its product is an authorized generic version of Minastrin 24 Fe tablets from Allergan Pharmaceuticals International Ltd. A combination medicine, Minastrin 24 Fe
BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has expanded its portfolio of women’s health products with the release of Femynor, a birth control pill. Amneal said Femynor (norgestimate and ethinyl estradiol tablets, 0.25 mg/0.035 mg) is a generic version of Ortho-Cyclen 28 from Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. Femynor is sold in a
NEW YORK — Mylan N.V. and Teva Pharmaceutical Industries Ltd. have rolled out norgestimate/ethinyl estradiol tablets, a birth control pill, in the United States. The companies said Tuesday that their products are generic versions of Janssen Pharmaceuticals Inc.’s Ortho Tri-Cyclen Lo tablets. Mylan said its norgestimate/ethinyl estradiol tablets — available in dosages of 0.18 mg/0.025
PITTSBURGH — Mylan N.V. has announced the U.S. launch of drospirenone and ethinyl estradiol tablets (3 mg/0.03 mg), an oral contraceptive. Mylan said Tuesday that the product, a generic version of Yasmin tablets from Bayer, is available immediately and represents its 13th oral contraceptive launch in the United States. Mylan’s partner Famy Care Ltd. received
MUMBAI, India — The Food and Drug Administration has granted Glenmark Generics Inc. USA final approval for levonorgestrel/ethinyl estradiol tablets (0.09 mg/0.02 mg), an oral contraceptive. Glenmark said Friday that its levonorgestrel/ethinyl estradiol tablets (0.09 mg/0.02 mg) are a generic version of Lybrel, which is no longer marketed in the United States. Lybrel is indicated
POTTERS BAR, England, and PITTSBURGH — Mylan N.V. has launched norethindrone and ethinyl estradiol chewable tablets (0.8 mg/0.025 mg) and ferrous fumarate chewable tablets (75 mg) in the United States. Mylan said Tuesday that its product is the first generic version of Warner Chilcott’s Generess Fe tablets, an oral contraceptive, and entitles it to 180
